These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6100036)

  • 1. [The use of 1-alpha-cholecalciferol in subjects treated for a prolonged time with diphosphonates for recurrent calcium nephrolithiasis].
    Jacobellis U; Salerno G; Ruotolo G
    Arch Esp Urol; 1984 Dec; 37 Suppl 1():577-81. PubMed ID: 6100036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of crystallization and calcium nephrolithiasis].
    Baumann JM
    Ther Umsch; 1980 May; 37(5):363-72. PubMed ID: 6248999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical treatment of urinary lithiasis].
    Baumann JM; Banic P
    Rev Med Suisse Romande; 1980 Nov; 100(11):981-5. PubMed ID: 6781026
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.
    Oata M; Pak CY
    Metabolism; 1974 Dec; 23(12):1167-73. PubMed ID: 4372511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metaphylaxis of nephrolithiasis].
    Uzdenov MA
    Urologiia; 1999; (5):15-7. PubMed ID: 11150146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What has been achieved in the therapy of calcium nephrolithiasis?].
    Tschöpe W; Ritz E
    Internist (Berl); 1979 Dec; 20(12):599-606. PubMed ID: 398355
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice.
    Mardis HK; Parks JH; Muller G; Ganzel K; Coe FL
    J Urol; 2004 Jan; 171(1):85-8. PubMed ID: 14665850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of calciuria and uricosuria in 220 patients with recurrent calcium nephrolithiasis].
    Mandressi A; Trinchieri A; Zanetti G; Rocco F
    Minerva Nefrol; 1980; 27(3):435-8. PubMed ID: 7231793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Patient compliance program aids therapy success].
    MMW Fortschr Med; 2009 Mar; 151(11):47. PubMed ID: 19469207
    [No Abstract]   [Full Text] [Related]  

  • 10. [Optimizing therapy in Paget disease].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):32. PubMed ID: 16402704
    [No Abstract]   [Full Text] [Related]  

  • 11. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis.
    Yasui T; Suzuki S; Itoh Y; Tozawa K; Tokudome S; Kohri K
    Urol Int; 2008; 81(2):135-8. PubMed ID: 18758209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etidronic acid and steroid therapy: new indication. No proven impact on fractures.
    Prescrire Int; 1999 Aug; 8(42):111-2. PubMed ID: 11503828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of concurrent therapy for patients with osteoporosis].
    Kobayashi S; Shiraki M; Takaoka K
    Clin Calcium; 2005 Apr; 15(4):661-5. PubMed ID: 15802781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of orthophosphate, pyrophosphate and diphosphonate in urinary-calculi metaphylaxis].
    Baumann JM
    Z Urol Nephrol; 1977 Jun; 70(6):449-52. PubMed ID: 198996
    [No Abstract]   [Full Text] [Related]  

  • 15. [Purine metabolism and recurrent nephrolithiasis].
    Müller MM
    Med Lab (Stuttg); 1981; 34(3):69-76. PubMed ID: 7231351
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical aspects of conservative therapy of nephrolithiasis].
    Kallistratos G
    Med Welt; 1972 Jun; 23(23):843-51. PubMed ID: 5040887
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of allopurinol in prevention of recurrences in calcic calculosis].
    Fiorelli C; Carini M; Nicita G; Rizzo M
    Minerva Urol; 1980; 32(3):153-60. PubMed ID: 7432330
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis.
    Ejaz AA; Zabaneh RI; Tiwari P; Nawab ZM; Leehey DJ; Ing TS
    Nephrol Dial Transplant; 1994; 9(10):1492-4. PubMed ID: 7816268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.